This success, announced Thursday, Nov. 6, is a world first.
A British baby a year old became the first in the world to cure leukemia through treatment with genetically modified immune cells, doctors announced, Thursday, November 6.
The small carrier Layla had been diagnosed with acute leukemia at the age of fourteen weeks. Following the failures of different treatments, doctors offered the family a test procedure under development.
This is to change the white blood cells from a healthy donor, so that these cells can overcome drug-resistant leukemia. The baby received a small injection of genetically modified cells and a few weeks later, experts have told his parents that the treatment had worked
& gt. Read: Babies three DNA: what are the international instruments that protect the genome?
A landmark achievement
“ His leukemia was so aggressive that such a response is almost a miracle ” said Professor Paul Veys, director of the Bone Marrow Transplant Unit of Great Ormond Street Hospital (GOSH) in London, where Richards was treated Layla. This success “a milestone in the use of new genetic technologies ,” said Waseem Qasim, medical specialist in immunology in the same establishment.
However, doctors have stressed that this experimental technique, potentially very promising, had been used only once and the results were to be reproduced. If the conclusions are positive again, celapourrait represent a major step forward in the treatment of leukemia and other cancers
La Croix (with AFP)